Niagen Bioscience, Inc. (NAGE)
NASDAQ: NAGE · Real-Time Price · USD
3.600
-0.070 (-1.91%)
May 20, 2026, 9:31 AM EDT - Market open
Niagen Bioscience Employees
Niagen Bioscience had 117 employees as of December 31, 2025. The number of employees increased by 13 or 12.50% compared to the previous year.
Employees
117
Change (1Y)
13
Growth (1Y)
12.50%
Revenue / Employee
$1,114,667
Profits / Employee
$159,291
Market Cap
287.32M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 117 | 13 | 12.50% | 117 | 0 |
| Dec 31, 2024 | 104 | -2 | -1.89% | 104 | 0 |
| Dec 31, 2023 | 106 | -7 | -6.19% | 106 | 0 |
| Dec 31, 2022 | 113 | -2 | -1.74% | 113 | 0 |
| Dec 31, 2021 | 115 | 5 | 4.55% | 115 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 2, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| REGENXBIO | 371 |
| Cellectis | 229 |
| Zentalis Pharmaceuticals | 106 |
| Silence Therapeutics | 88 |
| Armata Pharmaceuticals | 60 |
| Protara Therapeutics | 46 |
| Inhibikase Therapeutics | 35 |
| Eledon Pharmaceuticals | 33 |
NAGE News
- 9 days ago - Niagen Bioscience price target lowered to $11 from $12 at H.C. Wainwright - TheFly
- 12 days ago - Niagen Bioscience Announces Participation in Upcoming Investor Conferences - Business Wire
- 12 days ago - Niagen Bioscience price target lowered to $12 from $13 at Roth Capital - TheFly
- 13 days ago - Niagen Bioscience reports Q1 EPS 7c, consensus 6c - TheFly
- 13 days ago - Niagen Bioscience sees 2026 sales growth 10%-15% - TheFly
- 13 days ago - Niagen Bioscience Earnings Call Transcript: Q1 2026 - Transcripts
- 13 days ago - Niagen Bioscience Quarterly report: Q1 2026 - Filings
- 13 days ago - Niagen Bioscience Earnings release: Q1 2026 - Filings